Jay Kincannon
Professor
Also affiliated: Arkansas Children's Hospital (1996–2023); University of Arkansas Medical Center (1999); Arkansas Department of Agriculture (2001); University of Colorado Denver (1992)
Faculty Researcher
Dermatology, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Jay Kincannon is a Professor in the Department of Dermatology at the University of Arkansas for Medical Sciences, with a joint appointment in Pediatrics. He also serves as Chief of Pediatric Dermatology at Arkansas Children's Hospital. Dr. Kincannon's research interests include the treatment and diagnosis of various skin conditions, particularly in pediatric populations. His work has involved systematic reviews on treatment adherence in pediatric atopic dermatitis and the landscape of clinical trials for prurigo nodularis.
His clinical and research activities also encompass the study of rare dermatological presentations, such as annular erythema of infancy and corymbiform cutaneous disorders. He has investigated the clinical significance of screening electrocardiograms for propranolol administration in infantile hemangiomas and explored novel compound heterozygous mutations in ILNEB syndrome. Dr. Kincannon's scholarship metrics include an h-index of 12, with 32 total publications and 1,217 citations.
Research Overview
Jay Michael Kincannon, M.D. is a staff physician and Professor of Dermatology and Pediatrics in the Department of Dermatology at the University of Arkansas for Medical Sciences and Chief of Pediatric Dermatology at Arkansas Children's Hospital. Dr. Kincannon previously served as Interim Chairman of the Department of Dermatology between 2007-2009 and again in 2014-2015.Dr. Kincannon graduated with a Bachelor of Science degree in Zoology from the University of Arkansas at Fayetteville and received his medical degree from the University of Arkansas for Medical Sciences in 1985. His internship in Pediatrics was completed at the University of Colorado School of Medicine where he also completed residency training in both Pediatrics and Dermatology.Dr. Kincannon is an active member in several national academic organizations including the American Academy of Dermatology, the Pediatric Dermatology Society and the American Medical Association. He was the 1997 president of the Arkansas Dermatology Society. He has served on numerous committees and boards for academia and has presented at national and international summits. He is a member of Alpha Omega Alpha Honor Medical Society, and he has received yearly UAMS teaching awards, including receiving the Residency Educator Golden Apple Award numerous times.His research interests include vascular and pigmented skin lesions, birthmarks, pediatric skin diseases, human papilloma virus immunotherapy, vitiligo and cutaneous laser therapy. He cares for both adults and children at the UAMS Medical Center Dermatology Clinic. As section chief of pediatric dermatology at Arkansas Children's Hospital, he cares for the full spectrum of childhood skin disorders including treatment of vascular birth marks.Dr. Kincannon is board certified by the American Board of Pediatrics and the American Board of Dermatology.
Metrics
- h-index: 12
- Publications: 32
- Citations: 1,226
Selected Publications
-
Novel Compound Heterozygous Mutations in ILNEB Syndrome (2025)
-
Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review (2024)
-
Landscape of prurigo nodularis clinical trials (2024)
-
Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents (2024)
-
53413 The Buzz Behind Insect Repellents: Analysis of Safety Hazards, Marketing Claims, and Ingredients (2024)
-
Corymbiform cutaneous disorders in pediatric dermatology: <scp>Exploring</scp> this pattern of presentation beyond secondary syphilis (2024)
-
Annular erythema of infancy: A rare and challenging diagnosis (2023)
-
Cutaneous Oxalosis Due to Primary Hyperoxaluria (2022)
-
Hyperkeratotic Plaques of Distal Extremities as a Presenting Sign of Autoimmune Hepatitis: Challenge (2021)
-
Hyperkeratotic Plaques of Distal Extremities as a Presenting Sign of Autoimmune Hepatitis: Answer (2021)
-
Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas (2021)
-
A Three‐Year‐Old Girl Who Never Needs a Haircut (2016)
-
Reply (2009)
-
Agminated Spitz Nevi: Report of a Child with a Unique Dermatomal Distribution (2005)
-
Immunotherapy for Recalcitrant Warts in Children Using Intralesional Mumps or <i>Candida</i> Antigens (2003)
Grants & Funding
As listed on this researcher's institutional profile.
- Immunex Protocol No. 20040210 entitled Observational Post-Marketing Safety Surveillance Registry of Enbrel (etanercept) for the Treatment of Psoriasis Immunex Corporation Principal Investigator
Collaboration Network
Top Collaborators
- Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review
- Landscape of prurigo nodularis clinical trials
- 53413 The Buzz Behind Insect Repellents: Analysis of Safety Hazards, Marketing Claims, and Ingredients
- Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents
- Landscape of prurigo nodularis clinical trials
- 53413 The Buzz Behind Insect Repellents: Analysis of Safety Hazards, Marketing Claims, and Ingredients
- Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents
- Novel Compound Heterozygous Mutations in ILNEB Syndrome
- Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review
- Landscape of prurigo nodularis clinical trials
- 53413 The Buzz Behind Insect Repellents: Analysis of Safety Hazards, Marketing Claims, and Ingredients
- Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents
- Treatment Adherence in Pediatric Atopic Dermatitis: A Systematic Review
- 53413 The Buzz Behind Insect Repellents: Analysis of Safety Hazards, Marketing Claims, and Ingredients
- Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents
- 53413 The Buzz Behind Insect Repellents: Analysis of Safety Hazards, Marketing Claims, and Ingredients
- Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents
- Novel Compound Heterozygous Mutations in ILNEB Syndrome
- Landscape of prurigo nodularis clinical trials
- 53413 The Buzz Behind Insect Repellents: Analysis of Safety Hazards, Marketing Claims, and Ingredients
- Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents
- Cutaneous Oxalosis Due to Primary Hyperoxaluria
- Hyperkeratotic Plaques of Distal Extremities as a Presenting Sign of Autoimmune Hepatitis: Answer
- Cutaneous Oxalosis Due to Primary Hyperoxaluria
- Annular erythema of infancy: A rare and challenging diagnosis
- Cutaneous Oxalosis Due to Primary Hyperoxaluria
- Analysis of Ingredients, Safety Hazards, and Marketing Claims of Popular Insect Repellents
- Annular erythema of infancy: A rare and challenging diagnosis
- Corymbiform cutaneous disorders in pediatric dermatology: <scp>Exploring</scp> this pattern of presentation beyond secondary syphilis
- Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
- Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
- Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
- Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
- Clinical Significance of Screening Electrocardiograms for the Administration of Propranolol for Problematic Infantile Hemangiomas
Similar Researchers
Based on overlapping research topics